Integration of Surgical Strategies and Medical Treatment in the Management of Type 2 Diabetes Mellitus: An Interdisciplinary Approach
DOI:
https://doi.org/10.55204/trc.v3i2.e276Keywords:
Diabetes Mellitus Type 2, Surgical Procedures Operative, Metabolic Surgery, Medical Treatment, Patient Care TeamAbstract
Introduction: Managing Type 2 Diabetes Mellitus (T2DM) demands innovative approaches beyond conventional treatment. This article explores the integration of surgical and medical strategies, emphasizing the efficacy of metabolic surgery and an interdisciplinary approach. From improving glycemic control to reducing comorbidities, this approach promises to transform care for refractory T2DM patients.
Development: Addresses the complexity of managing Type 2 Diabetes Mellitus (T2DM) through surgical and medical strategies. In conventional treatment, we highlight medications like metformin and combined approaches. Metabolic surgery, including procedures like gastric bypass, shows substantial improvements in glycemic control and comorbidities.
Practical applications: Involve improving glycemic control and reducing comorbidities in Type 2 Diabetes Mellitus patients.
Conclusions: Integrating surgical and medical strategies in Type 2 Diabetes Mellitus management holds promising advancements. This comprehensive approach, supported by an interdisciplinary approach, not only optimizes glycemic control but also enhances the quality of life for patients.
Downloads
References
American Diabetes Association. (2020). Standards of Medical Care in Diabetes—2020. Diabetes Care, 43(Supplement 1), S1-S212.
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., ... & Rubino, F. (2012). Bariatric surgery versus conventional medical therapy for type 2 diabetes. New England Journal of Medicine, 366(17), 1577-1585.
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., ... & Bhatt, D. L. (2012). Bariatric surgery versus intensive medical therapy in obese patients with diabetes. New England Journal of Medicine, 366(17), 1567-1576.
Rubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G., Zimmet, P. Z., & Metabolic Surgery Summit delegates. (2016). Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care, 39(6), 861-877.
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., ... & Rubino, F. (2012). Bariatric surgery versus conventional medical therapy for type 2 diabetes. New England Journal of Medicine, 366(17), 1577-1585.
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., ... & Nissen, S. E. (2017). Bariatric Surgery versus Intensive Medical Therapy for Diabetes—3-Year Outcomes. New England Journal of Medicine, 376(7), 641-651.
Rubino, F., & Kaplan, L. M. (2010). Schauer PR. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Annals of surgery, 251(3), 399-405.
Purnell, J. Q., Selzer, F., Wahed, A. S., Pender, J., Pories, W., Pomp, A., ... & Hinojosa, M. W. (2016). Type 2 Diabetes Outcomes 1 Year After Metabolic Surgery: A Systematic Review and Meta-analysis. Diabetes Care, 39(2), 310-317.
Ikramuddin, S., Korner, J., Lee, W. J., Connett, J. E., Inabnet, W. B., Billington, C. J., ... & O'Brien, P. E. (2013). Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. Jama, 309(21), 2240-2249.
Arterburn, D. E., Bogart, A., Sherwood, N. E., Sidney, S., Coleman, K. J., Haneuse, S., ... & O'Connor, P. J. (2018). A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obesity surgery, 28(8), 2538-2546.
Cohen, R. V., Pinheiro, J. C., Schiavon, C. A., Salles, J. E., & Wajchenberg, B. L. (2012). Effect of gastric bypass surgery on the incretin and insulin responses to oral glucose in patients with type 2 diabetes. Diabetes, 61(9), 2238-2244.
Adams, T. D., Davidson, L. E., Litwin, S. E., Kim, J., Kolotkin, R. L., Nanjee, M. N., ... & Gress, R. E. (2017). Weight and metabolic outcomes 12 years after gastric bypass. New England Journal of Medicine, 377(12), 1143-1155.
Courcoulas, A. P., Goodpaster, B. H., Eagleton, J. K., Belle, S. H., Kalarchian, M. A., Lang, W., ... & Jakicic, J. M. (2014). Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Adriana Josseline Herrera Mejia, Andrea Estefanía Zapata Toapanta, Evelin Tatiana Pilco Rivera, Roberto Carlos Durán Almeida, María José Argüello Villamar, Luis Enrique Lagua Curipallo, Ruth Stefany Milan Lema, Sharon Norelia Pico Segarra
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the moral and patrimonial rights of their works. They only give to the magazine Tesla Revista Científica the right to the first publication of this. Since Tesla Revista Científica is an open access publication, readers can fully or partially reproduce its content as long as they properly credit the corresponding authors and the journal itself. Tesla Revista Científica undertakes not to make commercial use of the texts it receives and/or publishes.
Our journal is governed by the international policies SHERPA/RoMEO: Green journal: They allow the self-archiving of both the pre-print (draft of a paper) and the post-print (the version corrected and reviewed by peers) and even the final version ( layout as it will be published in the journal).
See also "Copyright and licences".
